Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
In light of the one year anniversary of The London Declaration, a series of events took place in London this week that that continued to highlight the important role neglected tropical disease (NTD) control and elimination plays on the global health and development agenda.
On January 23, Mongolia held its first ever National Parliamentary briefing on sustainable immunization financing (SIF). SIF Senior Program Officer Khongorzul Dari reports that the meeting was a big success.
Heather Ignatius, a senior policy and advocacy officer with PATH’s Advocacy and Public Policy team in Washington, DC, recently wrote about her thoughts on global health and development priorities for the second-term Obama administration and the 113th Congress. Thanks to PATH for allowing us to share her piece. Photo credit: PATH/Mike Wang